Sometime during the mid-nineties, Dr. Rannier F. Reyes, together with a researcher colleague from Denmark, formulated an oral rinse utilizing chlorhexidine. Knowing that the Cationic compound gives a very bitter and metallic taste, they formulated a new compound that minimized the chlorhexidine taste and made an oral rinse that was more acceptable to the user. Orahex, the brand name for the oral rinse, was initially sold to the dentists.
Pharmahex, Inc. was registered with the Securities and Exchange Commission on December 27, 1999. The primary purpose of the Company, as stated in its Articles of Incorporation, is to manufacture goods such as antiseptic for cosmetic and medicinal purposes and to trade the same on a wholesale retail basis. The Philippine Bureau of Food and Drugs granted the Company a license to operate as a cosmetic manufacturer of mouthwash on Feb. 16, 2000.
Orahex has slowly gained acceptance and recognition by dentists in the Philippines. A new variant, utilizing a higher percentage of chorhexidine has also been produced and is available in the market. These products are now being sold to dentists and doctors and in hospitals and pharmacies around the country. Knowing the limitations of a one-product portfolio, the shareholders decided to go beyond the oral rinse market and develop a line of various produced line suited for doctors and dentists treating problems related to oral health. Other products currently being registered with the Bureau of Food and Drug in the Philippines are paracetamols with various acting pain-relievers and a toothpaste line.
DR. JOSE O. JULIANO
Jose O. Juliano is the Chairman of the Board of Pharmahex, Inc. He is a chemist by profession, having obtained his Ph.D. degree in Nuclear Chemistry from the University of California, Berkeley in 1957.
He has been a Professor of Chemistry at the University of the Philippines, Plant Manager of Unilever Philippines, President of Interphil Laboratories, the largest toll manufacturer of pharmaceutical products in the Philippines and a sister company of Interthai, Undersecretary of Trade and Industry during President Ramosí presidency, and now the President of Calamba Medical Center, Inc, the largest hospital in Southern Luzon.
Dr. Juliano is also a member of several listed companies such as Mabuhay Vinyl Corporation, Interphil Laboratories, Zuellig Foundation, Calamba Medical center, Southern Luzon Hospital and Medical center, Luzon Development Bank, St John Colleges, Calamba Eye Center, Alabang Eye Center, etc. Dr. Juliano has been posted in the Netherlands, United Kingdom, Israel and the United States and recently established a pharmaceutical company in North Korea.
DR. RANNIER F. REYES
Dr. Rannier Reyes is the President of Pharmahex, Inc. He is a graduate of the University of the Philippines, College of Dentistry. He then completed his post-graduate training and fellowship in Periodontolology at the Royal Dental College in Aarhus, Denmark. He has been in private practice ever since his return to the Philippines. Dr Reyes is concurrently the President of the Philippine society of Periodontology, vice president of The Filipino Academy of Aesthetic dentistry and a member of the Philippine Dental Associations' speakersí bureau, a group tapped by the national dental association to give lectures nationwide.
Dr. Reyes has also business interests. He has a trading firm, Inno-Pro Traders, which is a dealer of various medical and dental products. He has interests in various restaurants around Metro Manila. Dr. Reyes, together with a researcher colleague from Denmark, is responsible for developing the oral rinse that Pharmahex presently manufactures and sells.
EULOGIO F.B. NAKPIL, JR.
Joey Nakpil is the Managing Director of Pharmahex, Inc. He graduated from the University of the Philippines with a Bachelor of Science degree in Mathematics in 1979. He also holds a Masters in Business Management degree from the Asian Institute of Management, where he graduated in 1985.
Until 2002, he held various senior management positions in the Zuellig Group of Companies, where he was employed for 12 years. Prior to his retirement from the Group, he was posted to Singapore and Hongkong, where he held the positions of Chief Financial Officer and subsequently Business Development Director for companies of the Group. During this period, he was also the Comptroller for the Zuellig holding company in the Philippines and held directorships in various companies around the region.